Gilead, Vertex initiated as new big biotech buys at Citi
Citi has started coverage of Gilead Sciences (NASDAQ:GILD) and Vertex Pharmaceuticals (NASDAQ:VRTX) at buy saying the former will benefit from short-term growth of Biktarvy (bictegravir, emtricitabine ...
Investor's Business Daily on MSN1h
Stock Market Today: Chevron Breaks Out, Disney Gets Some Of Its Mojo Back (Live Coverage)
Investors saw multiple shades of red in the stock market today. But some sectors showed strength. Beazer Homes broke out on earnings and ran past a new buy point of 35.20 in a seven-week base. Some ...